The Global Market for Anticoagulants (2018-2025): Analysis by Drug Class, Route of Administration and Application - ResearchAndMarkets.com

August 24, 2018

DUBLIN--(BUSINESS WIRE)--Aug 24, 2018--The “Anticoagulants Market by Drug Class, Route of Administration, and Application, Pulmonary Embolism, and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025” report has been added to ResearchAndMarkets.com’s offering.

The global anticoagulants market was valued at $24,265 million in 2017, and is expected to reach $43,427 million by 2025, growing at a CAGR of 7.5% from 2018 to 2025.

The global anticoagulants market is expected to grow at a significant rate during the forecast period, owing to increasing prevalence of venous thromboembolism (VTE) and cardiovascular disease across the world, growing adoption of novel oral anticoagulants (NOACs), and growing awareness of NOACs in developing regions.

Furthermore, increasing obese and geriatric population and growing demand of novel therapeutics are anticipated to further influence the market growth during the forecast period.

On the other side, higher price of NOACs and lack of antidots for NOACs impede the market growth.

Profiles for:

Key Players

Aspen Holdings Bayer AG Boehringer Ingelheim GmbH Bristol-Myers Squibb Company Daiichi Sankyo Company Ltd. GlaxoSmithKline PLC Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Pfizer Inc. Portola Pharmaceuticals Inc. Sanofi S.A.

Other Players

Armetheon Inc. Astrazeneca Celgene Corporation

Key Topics Covered

Chapter 1: Introduction

Chapter 2: Executive Summary

Chapter 3: Market Overview

Chapter 4: Anticoagulants Market, by Drug Class

Chapter 5: Anticoagulants Market, by Route of Administration

Chapter 6: Anticoagulants Market, by Application

Chapter 7: Anticoagulants Market by Region

Chapter 8: Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/jlbk3s/the_global_market?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180824005121/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Cardiovascular Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/24/2018 06:37 AM/DISC: 08/24/2018 06:37 AM


Update hourly